by Brooke Blazr | Sep 29, 2026 | High Dispatch
So yes, today’s cannabis is stronger, and yes, a meaningful minority of frequent users are developing a real use disorder. That’s a serious finding and it deserves serious attention: better product labeling, potency caps or graduated taxation on high-THC...
by Brooke Blazr | Sep 28, 2026 | High Dispatch
A slew of medical cannabis import and export data from many of the world’s top cannabis industry markets has been published in recent weeks, and it’s clear that global cannabis is starting to hit its stride. The import and export market landscape is also evolving....
by Brooke Blazr | Sep 28, 2026 | High Dispatch
Mid Hudson News ran a piece last week headlined “CDC study links marijuana uses to health risks,” reporting that “marijuana was listed as a cause of death in 1 percent of the 209,166 overdose deaths reviewed over the past five years.” That...
by Brooke Blazr | Sep 25, 2026 | High Dispatch
Pier 36 filled up fast on Friday, Sept. 18, as exhibitors and buyers from across the country came out for Revelry Buyers’ Club, New York’s homegrown cannabis trade show hosted by On the Revel. This year’s edition ran a single day instead of the usual two, drawing a...
by Brooke Blazr | Sep 25, 2026 | High Dispatch
This analysis reveals why Portugal’s health-first drug policy succeeded while Oregon’s Measure 110 collapsed. Discover the critical role of funded treatment infrastructure, supervised medical management, and what true harm reduction actually...
